Insiders bluebird bio, Inc.

Equities

BLUE

US09609G1004

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-21 pm EDT			5-day change	1st Jan Change
0.9967 ^USD	-3.23%		-6.85%	-27.78%

May. 16	Transcript : Bluebird bio, Inc. Presents at Bank of America Health Care Conference 2024, May-16-2024 10:00 AM
May. 09	Transcript : Bluebird bio, Inc., Q1 2024 Earnings Call, May 09, 2024

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bluebird Bio, Inc. Appoints Richard Paulson to the Board as Class III Director, Effective April 3, 2023	23-03-29	CI
Bluebird bio, Inc. Appoints Joseph Vittiglio, JD as Chief Business and Legal Officer	23-01-03	CI
Bluebird bio, Inc. Appoints Christopher Krawtschuk as Treasurer, Principal Financial Officer and Principal Accounting Officer	22-11-07	CI
Bluebird bio, Inc. Announces Executive Changes Effective October 14, 2022	22-09-23	CI
Bluebird Bio Chief Strategy, Financial Officer Jason Cole to Leave in October	22-09-12	MT
Bluebird bio, Inc. Announces Executive Changes	22-09-12	CI
Bluebird bio, Inc. Appoints Tom Klima as Chief Commercial & Operating Officer, Effective August 8, 2022	22-08-04	CI
Bluebird bio, Inc. Appoints Jason F. Cole as Principal Accounting Officer	22-05-02	CI
Bluebird bio, Inc. Announces Executive Changes	22-03-07	CI
Bluebird bio, Inc. appoints Charlotte Jones-Burton as Class I director, effective March 7, 2022	22-03-04	CI
Bluebird bio, Inc. Announces Resignation of Jessica Whitten as Chief Accounting Officer and Principal Accounting Officer	22-02-04	CI
Bluebird Bio, Inc. Announces Resignation of Wendy L. Dixon as Director, and Its Audit Committee and Compensation Committee	21-11-23	CI
Bluebird Bio, Inc. Announces Board and Committee Appointments	21-10-05	CI
Bluebird Bio, Inc. Announces Executive Appointments	21-09-07	CI
Bluebird Bio, Inc. Appoints Gina Consylman as Chief Financial Officer	21-09-07	CI
Bluebird Appoints Thomas J. Klima as Chief Commercial Officer, Severe Genetic Disease, Effective May 10, 2021	21-05-05	CI
Bluebird bio, Inc. Announces Employment of David Davidson, as Chief Medical Officer Ends on April 16, 2021	21-03-16	CI
Bluebird Bio, Inc. Announces Executive Changes	21-02-09	CI
Bluebird Bio, Inc. Appoints Ramy Ibrahim as Director	21-01-11	CI
Bluebird Bio, Inc. Announces Executive Changes	21-01-11	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders bluebird bio, Inc.

Equities

BLUE

US09609G1004

Insiders

Filters